www.fdanews.com/articles/70360-glenmark-pharma-shasun-chemicals-enters-into-agreement
Glenmark Pharma, Shasun Chemicals Enters Into Agreement
March 28, 2005
Glenmark Pharmaceuticals Ltd and Shasun Chemicals and Drugs Ltd have entered into a collaboration agreement for the joint development, filing and marketing of twelve generic pharmaceutical products for the U.S. market. The product list includes a mixture of off-patent and patent-protected molecules with cumulative annual safes in the U.S. of about US$8 billion.